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Abstract
In addition to the conventional techniques used in radiotherapy, certain procedures, 
special-called for the treatment of both some cancer diseases and clinical application are 
usually required. Such practices typically manifest a technical problem with respect to 
the equipment used, which requires important adjusts that diverge significantly from the 
standard implemented in the common treatments. Total body irradiation is one of those 
special techniques, in which the radiation target is the entire patient body. In a broad 
sense, the concept covers all radiation processes with photon beam fields more wide 
than standard field size. Treatment with total body irradiation is usually applied with 
purpose of providing immunosuppression to prevent rejection in bone marrow trans-
plantation procedure. Diseases such as aplastic anemia and a varied number of leuke-
mia and lymphomas respond favorably to this treatment scheme. Beams of megavoltage 
photons, such as Cobalt sources and linear accelerators, are used for such purposes. In 
this chapter, the technique will be studied analyzing its definition and first applications. 
The chapter includes a description of the main treatment schemes on which it is based, 
covering the calibration process, ergonomic criteria as well as the main contributions in 
the clinical research field, opportunity fields and novel research perspectives.
Keywords: total body irradiation, radiotherapy, lineal accelerator, non-conventional, 
in vivo dosimetry, portal imaging, ergonomics
1. Introduction
Radiotherapy, surgery and chemotherapy are the three main modalities used in oncology for 
the treatment of diseases caused by malignant cells [1, 2]. Unlike other medical specialties, 
which essentially maintain their sureness in the clinical knowledge and experience of the 
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medical specialist, in radiotherapy, due to the use of ionizing radiations, it is required besides 
the confidence in modern technologies, as well as the nearest collaboration of many other 
professionals. The radiotherapy team consists of a group of oncologists, medical physicists, 
dosimetrists, nurses and technicians [3], all with different levels of training, but with a goal, 
the need to understand the physical basis of radiation therapy.
Radiotherapy is a specialized discipline in the field of medicine, which involves the use of 
high-energy ionizing radiation for the treatment of cancer cells [4]. The radiation sources 
used in this clinical field can be located throughout internally to the patients (brachytherapy) 
or external way (teletherapy). During the first 50 years of radiotherapy, technological prog-
ress was relatively scarce and based mainly on X-ray tubes, Van de Graaff generators and 
Betatrons. The invention of the Cobalt 60 machine [5] around 1950 by Harold Elford Johns in 
Canada, gave a new twist to the radiotherapy technique, becoming for several decades the 
most important tool for cancer treatments (Figure 1).
However, the most widely used system for radiotherapy treatments today is the use of Linear 
Accelerators (Linac). The concurrent development of this system overshadowed the extraor-
dinary impact of the 60Co source, becoming the most widely used radiation source in modern 
radiotherapy.
Conventional radiotherapy is usually focused on traditional studies (breast cancer, cervical 
cancer, etc.) where the equipment is calibrated (Figure 2) for radiation beam emission with 
remote settings of 1.00 m and maximum radiation fields of 0.40 × 0.40 m [6, 7].
In addition to these conventional techniques, several procedures, special-called, for the treat-
ment of certain diseases and clinical applications are required. Such procedures manifest a 
technical problem in essence because the equipment used requires certain modifications that 
diverge significantly from the adjustments implemented in the more common treatments. 
Total body irradiation (TBI) is one of those special techniques, in which the radiation target is 
the entire patient body. In a broad sense, the TBI concept covers all radiation processes with 
Figure 1. 60Co clinical unit (Theratronics, Ottawa, Canada). Courtesy of Ing. Antonio Almonte, from Dr. Heriberto Pieter 
Cancer Center, Santo Domingo, Dominican Republic.
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long radiation fields, that is, with fields larger than the standard maximum of 0.40 m × 0.40 m. 
Megavoltage photon beams, such as Cobalt-60 sources and linear accelerators, are used for 
such purposes.
2. Total body irradiation
TBI is a technique accepted as radiotherapy treatment and frequently used in combination 
with chemotherapy as a complementary regimen for bone marrow transplants [8, 9]. Diseases 
such as aplastic anemia [10] and a varied number of leukemia and lymphomas [11, 12] respond 
to the TBI treatment. Ewing’s sarcoma, advanced non-Hodgkin lymphomas, lung cancer and 
lymphosarcoma have also been treated in combination with TBI therapy [13].
The first applications of TBI date back to the early twentieth century, when in 1907 the German 
Friedrich Dessauer published the first work that has been recorded [14]. Another of the pio-
neering works on TBI, carried out in the United States, corresponds to the studies done by 
Heublein [15], who implemented an arrangement in which four patients could be irradiated 
simultaneously using a Coolidge tube.
A large number of authors have worked on the implementation of different arrangements for 
TBI applications, being probably the irradiation technique that considers the beam of radia-
tion in a fixed position and keeps the patient in vertical position, the most commonly used 
Figure 2. Varian linear accelerator for clinical use, and the basic equipment for radiotherapy calibrations. (A) 
Computerized water phantom system, (B) PTW ionization chamber N31003 no. 975; (C) Scanditronix Wellhofer; (D) 
Fixed computer system; and (E) Keithly CNMC electrometer. Courtesy of Dr. Carlos Esquivel, from Cancer Therapy & 
Research Center, San Antonio, Texas, USA.
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by different cancer centers. However, the experimental results usually show significant varia-
tions in the dose levels between patients, which represent a poor reproducibility of the differ-
ent protocols. These discrepancies may be influenced, to some degree, by illness and patient 
fatigue associated with chemotherapy sessions, which makes it difficult for many patients to 
remain in the proper treatment position during prolonged exposure times.
Many of the first clinical experiences with TBI were carried out in centers with special designs 
and facilities. However, and due to the increased need to treat an important variety of dis-
eases, patients are now commonly treated in commercial units.
2.1. Treatment schemes for TBI
Basically, the TBI treatments fall inside two general categories: bilateral irradiation (lateral 
TBI) and antero-postero total body irradiation (AP-PA TBI). At the first one [16], patient is 
collocated up treatment bed, so the radiation beam is perpendicularly to the sagittal patient 
plane (Figure 3). In AP-PA TBI [17], on the other hand, the patient is placed in an anatomi-
cal position, either maintained vertically or installed in some arrangement designed so that 
the radiation beam is perpendicular to the patient coronal plane (Figure 4). In both cases, 
the patients are positioned in such a way that it can be completely covered by the area of the 
projected field. For what usually require the patient collaboration, such as asking the patient 
to bend their knees, in order to adequately cover the projected field.
TBI is normally implemented with the aim of achieving a homogeneous distribution of the dose 
at the level of the patient’s median plane. However, the parameters such as the irregularities 
and thicknesses of the areas of the patient’s contours to be irradiated have dimensions much 
greater than those observed in any other radiotherapy treatment therapy. Such considerations 
Figure 3. Image taken during one of the treatment sessions for lateral TBI at the Cancer Therapy & Research Center, San 
Antonio, Texas, USA. Image taken by Francisco Mesa.
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seem to be more widely observable during the treatments of Lateral TBI, where in addition, the 
armoring technique of critical organs, such as the lung, does not turn out to be as efficient in 
practice as in the case of applications in AP-PA TBI.
The implementation of compensating filters is one of the most important procedures used 
in TBI for the correction of heterogeneity in the distribution of the dose. The arrangement 
formed by several sheets of lead of different thicknesses (Figure 5) allows the attenuation of 
the dose levels supplied, so that for a specific amount of Monitor Unit (MU) applied, different 
dose levels can be registered in the different contours of the body, in order to achieve the same 
distribution of the dose at the level of the patient’s median plane. The considerable reduction 
of the dose levels with respect to the build-up zone (space or depth between the surface and the 
point of maximum ionization, and which is characteristic of each energy and type of radia-
tion) is another factor to be considered regarding of the TBI applications. Such a reduction 
entails the application of percentages of much lower doses in skin, than the percentages in the 
rest of the body.
2.2. Dosimetric calibrations for TBI
The basic dosimetric parameters for TBI are the same as for standard radiotherapy, including 
dose rate, percentage depth dose (PDD), tissue-maximum ratio (TMR) and beam profiles (Table 1). 
However, these parameters must be measured under the specific conditions of TBI in order to 
obtain relevant data for clinical use (Figure 6). Many dosimetric problems related to the use of 
phantom and also radiation detectors should be considered for this type of non-conventional 
applications. In contrast to standard radiotherapy, for example, water phantoms are generally 
smaller than the field sizes and also smaller than the patient’s dimensions. This causes differ-
ent dispersion conditions that can generate adverse beam effects.
Figure 4. Illustrative diagram of the positioning of the patient during the implementation of the treatment. A vertical 
platform 0.015 m thick acrylic (polymethylmethacrylate) is placed in front of the patient to increase the skin dose.
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Basically, the material, equipment and general instrumentation for TBI consists of a lineal 
accelerator (i.e. Varian, Siemens, etc.) for clinical use; a solid water phantom (i.e. PMMA, 
RW3,); ionizing chambers (i.e. FC65-P Scanditronix Wellhӧfer Farmer FC65/IC69; CC13 
P-CC13–510-001 02); the Scanditronix Wellhofer (Farmer Scanditronix Wellhofer); a fixed 
basic computer system; a Keithly CNMC electrometer; a portal X-ray equipment for lateral 
or AP-PA linac-portal radiographs; a 1.2-cm acrylic beam spoiler and tray at the head of the 
gantry and thermoluminescent dosimeters for in vivo dose verification.
The determination of the type of energy used for the applications of TBI is a factor of high 
importance and depends on many dosimetric factors and clinical criteria.
The photon beams used for TBI have essentially the following properties: (a) point of maxi-
mum ionization is below the surface, registering, for example, for the energies of 6–18 MV, at 
depths of 0.018–0.032 m in water (Figure 6); (b) when is higher energy of the radiation beam, 
the lower the percentage of the dose is recorded on the surface; (c) photons have a high pen-
etration power, registering dose levels of approximately 0.20–0.30 m deep with similar values 
to the surface, for energies of 6–18 MV, respectively; (d) below the “build-up” zone (maximum 
ionization), the PDD have greater intensity in photons of 18 MV than of 6 MV (Figure 7).
When reviewing the literature, a wider use consideration of energies of 6 MV of photons for 
TBI treatments is observed. However, a broader and more detailed discussion about the need 
and criteria of using one or another type of energy is necessary.
Figure 5. Design of the attenuation filters used to generate a homogeneous dose distribution at the level of the patient’s 
median plane. Filter arrangements was calculated and designed to the contour of each patient. Courtesy of Cancer 
Therapy & Research Center, S.A., TX.
Medical and Biological Image Analysis94
2.3. Treatment planning
The treatment planning stage (simulation) consists of location and identification of the area of 
the body to be irradiated, as well as the definition and recording of the geometric conditions 
and physical parameters related to the patient placement and installation. For the Lateral TBI 
scheme, patients are placed on the treatment bed, placed in the supine position with the knees 
Dosimetric parameters Conventional radiotherapy Total body irradiation
Field size ≤0.40 m × 0.40 m >1.20 m
Patient treatment distance 1.00 m >3.00 m
Dose rate 0.05 Gy/s 0.00166–0.025 Gy/s
Dose per section 1.50 Gy/session 1.00 Gy/session
Total dose 40–50 Gy 12 Gy
Treatment technique Source-surface distance/isocentric Isocentric
Radiation source Cobalt 60/lineal accelerator Cobalt 60/lineal accelerator
Additional equipment No Compensation filters/special treatment bed
Calibration phantom Computerized water phantom system Solid phantom
Radiation detectors PTW ionization chamber; Scanditronix 
Wellhofer; fixed computer system; Keithly 
CNMC electrometer
PTW ionization chamber; Scanditronix 
Wellhofer; fixed computer system; Keithly 
CNMC electrometer
In vivo dosimetry No Yes
Number of sections 1 dairy/20–40 day 2 dairy/3 day.
Table 1. Comparisons between the different dosimetric parameters that intervene in the both conventional treatment 
process and TBI. Description: Gy = Gray.
Figure 6. Experimental set-up for TBI calibration with a linear accelerator at the treatment distance (3.50 m), and an 
ionization chamber installed inside the PMMA solid phantom. Calibration process conduced at the Cancer Therapy & 
Research Center, San Antonio, Texas, USA. Courtesy of Dr. Carlos Esquivel, from Cancer Therapy & Research Center, 
San Antonio, Texas, USA.
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in flexion, and placing the hands together on the abdomen. The arms in this position can serve 
as partial shielding of the lungs.
In the case of AP-PA TBI, for other hand, patient is placed in a kneeling chair position (Figure 4), 
and it is supported with its hands through handlebars set, holding in the chest by means of a 
holding strap, which keeps it in a fixed and stable position throughout the entire process. The 
assembly is installed inside an arrangement formed by stainless steel bars placed on a mobile 
base, occupying a space of 0.80 × 0.50 × 2.00 m. The system includes several cushions for the 
head, back and knee, in order to keep it in a comfortable position during the treatment ses-
sions. In each case, dosimetrist must make sure that the patient is placed in a position that is 
comfortable and placed in such a way that it is completely localized in the projected radiation 
field. The contours of anatomical regions of interest (Table 2) are marked with permanent 
ink during this stage of the process. The regions of interest are usually identified in the head, 
neck, shoulders, breasts, abdomen, hips, thighs, knee and ankle.
The measurement of the greater thickness contour, the distance of the patient’s surface area, 
the compensations (offset), the depth (thicknesses) of the contours (right–left, left–right, 
anterior–posterior, posterior–anterior), and all geometric parameter measurements were 
recorded at this stage of the procedure. Geometrical projections on the Gantry head, with 
respect to the different contours previously selected, in order to calculate the dimensions of 
the arrangement of sheets used for the design of the compensating filters, are determined. 
Subsequently, a radiographic plate of the lung is taken, which is used as a reference for the 
design of the protective lung blocks (Figure 8). For the treatment application, patients are 
usually cited a week after being subjected to the simulation process, and they are placed in 
a similar way to that process. Patients are placed inside a prismatic square box (for Lateral 
TBI) or stainless steel bars assembly (for AP-PA TBI). For the last one, 0.015 m thick acrylic 
(polymethylmethacrylate) vertical platform in front of the patient in order to increase the skin 
dose, was installed (Figure 4).
The system is installed at a suitable source-axis distance (SAD), with respect to the median plane, 
and in such a way that it is completely located in the field projected by the light output of the lin-
Figure 7. Behavior of the PDD for 6–18 MV photon beams, obtained with a Clinac 21EX linear accelerator, at the medical 
unit of high specialty, Mexican Institute of Social Security, form León, Guanajuato, Mexico.
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ear accelerator head. Once the patient is installed in the treatment position, the lead attenuation 
filters are placed and aligned to them so that their projections coincide with the contour marks 
of the anatomical regions indicated in the simulation process.
2.4. In vivo dose verification
In vivo dose verification are usually developed during the first treatment sessions with TLD-
100 dosimeters previously characterized.
The TLD-100 is probably the best known dosimeter and the most widely used for clinical 
applications [18–23]. It was developed by J. R. Cameron in 1968 [24]. Chemically, it is com-
posed of lithium fluoride doped with magnesium and titanium impurities (LiF, Mg, Ti). 
Widely accepted and commercially used, the TLD-100 is basically presented in the form of 
chips, with dimensions of 0.0032 m × 0.0032 m × 0.0009 m. They allow dose measurements 
between 10−6 and 1 Gy, in the linear response range; they present a high precision for mea-
surements registration (from 1 to 2%); having 2640 kg/m3 of density and an effective atomic 
number equal to 8.2, close to the biological tissue.
The dosimeters are placed at specific points of interest located in each contour defined in the 
simulation process (Table 2). They are installed on the skin of the patient under a few pieces 
Anatomic 
contours
Anatomic localization descriptions
Lateral TBI AP-PA TBI
Head Along the longitudinal axis of the skull at the level of the 
pituitary fossa
Reference point defined along the 
longitudinal axis of the skull
Neck Reference point defined along the patient’s longitudinal axis at 
the level of C3/C4
It is not usually included
Shoulder This reference point is defined as just inferior to the lateral 1/3 
of the clavicle
Shoulders, lower zone 1/3 of lateral 
distance of clavicle
Chest Along the patient’s longitudinal axis at the level of the angle 
of Louis
Midline at the level of the sternum 
head
Abdomen This reference point is defined as the point along longitudinal 
axis midplane at the level of the umbilicus
Point along navel level
Hip Defined along the patient’s longitudinal axis at the center of 
the pelvis at a level that is 1.0 cm superior to the symphysis 
pubis
Proximal femur at the level of the 
major trochanter
Thigh It is not usually included Mean distance between the ends of 
the femur
Knee Along the midline in the midplane of the knee at the level of 
the middle of the patella
Knee, at the level of the middle of the 
kneecap
Ankle Defined along the middle of the ankle at the level of the lateral 
malleolus
Tibia-fibula intersection
Table 2. Anatomical description of contours and location of points for dosimeter installation during dose verification for 
both lateral TBI and AP-PA TBI.
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(bolus) of tissue-equivalent material, to produce the maximum 0.015 m dose (build-up) in each 
reading. The dose verification at the level of the median plane is calculated for each contour by:
  D 
Midplan
  =   L TLD (nC) ×  CF TLD ( cGy ⁄ nC )   ________________ ISL × TMR (1)
where  L 
TLD
 is the raw thermoluminescence reading;  CF 
TLD
 is the calibration factor for TLD;  ISL is 
the inverse-square factor and  TMR is the tissue-maximum ratio.
2.4.1. Other in vivo dose detectors
Although thermoluminescent dosimeters are the most widely used detector for in vivo dose 
verification in total body irradiation, the development and implementation of new methods to 
determine dose levels during treatment sessions has been increasing. The use of Gafchromic 
EBT films [25–27], EDP-30 diodes [28] and other semiconductors [29] has been considered as 
an important alternative to achieve a more accurate and timely in vivo dosimetry.
However, the need to develop detectors for in vivo dosimetry that determine dose levels in a 
real time sense during the application of unconventional radiotherapy treatment continues to 
be an open opportunity for the scientific community.
3. Opportunity fields and novel research perspectives
Total Body Irradiation is a complex treatment modality that requires careful planning to spec-
ify the homogeneity in the dose distribution, as well as the location of the organs that will 
receive a reduced dose, or that must be completely shielded from the radiation beam.
Figure 8. Lung radiography used for design of protective lung blocks. The distances from the medial plane to the medial 
side of the lung ( D 1  / 2 ) and the lateral side of the lung ( D 2  / 2 ) are shown.
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Even though in general terms, aspects associated with the planning of radiation treatment 
have a scientific and methodological support regulated by international organizations through 
reports and recommendations [6, 7], it should also be considered that these regulations are 
essentially based on protocols associated on conventional radiotherapy. Regulations about the 
calibration processes based on the use of solid phantom and specific dosimetric settings for 
treatment distances greater than the standard (0.40 m × 0.40 m) are necessary for the strength-
ening of the technique. Similarly, the need to provide more evidence on the evolution of the 
tumor and its behavior in the face of the effect of radiation is evident [30]. Other criteria associ-
ated with the evaluation of different physical, biological, environmental and even perception 
variables could have a significant impact on the evolution of patients’ health status.
The identification of anthropometric parameters, which are usually performed only during 
the first stage in treatment planning, and associated with certain very specific protocols, could 
provide relevant information regarding early recovery in patients with chronic diseases. In 
this sense, when reviewing the literature, it is clear the need to develop research works that 
provide more accurate information about the adequacy homogeneity in the distribution of 
doses during treatment sessions, as well as the location of organs that will receive a reduced 
dose or that must be “shielded” completely with respect to the radiation beam.
It is also observed the need to design ergonomic mechanisms that guarantee greater stability 
and comfort of the patients during the considerable treatment times. Together with the need 
for calculation and calibration systems with greater precision and accuracy, as well as the 
performing of in vivo dosimetry with greater reproducibility during treatment, constitute 
important opportunity areas for TBI.
4. Conclusions
De conventional radiotherapy concept, usually focused on traditional studies where the 
equipment is calibrated for radiation beam emission with remote settings of 100 cm and 
a maximum radiation fields of 0.40 m × 0.40 m, and is differences respect to TBI, as a 
non-conventional treatment scheme, was described. The TBI protocol has been carried out 
following the recommendations on clinical dosimetry calibrations of the TG-51 report [6], 
as well as the recommendations regarding the physical aspects of total body radiation 
provided by TG-29 [31]; last one published at 1986, what motivates the need to promote 
studies for its update according to the development of new technologies.
The protocol presented includes the development and description of the calculation process to 
determine both the dimensions and thicknesses of the dose compensation filters used to obtain 
a homogeneous dose distribution at the level of the patient’s median plane. It also includes the 
development of thermoluminescent dosimetry for the verification of in vivo doses during the first 
sessions of treatment. The protocol was presented in two modalities: Lateral TBI and AP-PA TBI. In 
the first modality, the patients were placed on a treatment table, in supine position, with the knees 
bent upwards, inside a square prismatic box constructed of acrylic, and in such a way that they 
were completely inscribed in the projected field. In the second one, however, the patients were 
positioned within an arrangement designed for such purposes, where they were seated, adopting 
a kneeling chair position, and irradiated in AP and PA fields during each treatment session.
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Basically both treatments have been made to be applied under the same medical prescriptions; 
however, the use of one or the other tends to depend essentially on the anthropomorphic char-
acteristics, body type (size, size), and the type of cancer and stage of the cancer presented by 
the patients, as well as on the degree of precision desired of a certain specific part of the body.
When observing the experimental results of both techniques, obtained during the in vivo 
dose verification process, better levels of precision are observed with respect to the values 
registered for the Lateral TBI technique, which promotes, from this point of view, greater 
reliability regarding the other technique. It is also more convenient to apply this technique, 
when it is required to install the patient in a position of greater comfort, either by the state of 
fatigue or by the degree of disease that it presents. Treatments in AP-PA, conversely, are more 
convenient to perform when a more homogeneous dose distribution is desired at the level of 
the whole body. While the lung protection system adequately reduces the dose at the level of 
the lung, it is also true that this reduction affects a body area of greater area, thus generating 
a reduction in dose levels with respect to the different contours adjacent.
On the other hand, the AP-PA technique is also suitable for patients with greater body propor-
tions such as: anthropometry, height, diameter, because they have a better location within the 
projected radiation field, as well as in obese patients, where a significant part of your chest or 
abdomen could result in a definition of a greater degree of irregularity in the corresponding 
contour, with respect to the other contours of the body.
It is important to note that both arrangements were implemented using the same facilities of 
a conventional radiotherapy treatment room, which is important mainly because it facilitates 
the implementation of both protocols in any standard radiotherapy unit.
The chapter covered the basic dosimetric parameters for TBI, calibration process and it com-
parison with respect to the standard radiotherapy adjusts. A description about the in vivo dose 
verification system with thermoluminescent dosimetry and other detector used was discussed, 
as well as the need to develop detectors for in vivo dosimetry that determine dose levels in a real 
time sense during the application of unconventional radiotherapy treatment was presented.
Finally a description about important opportunities field, future discussions and novel 
research perspectives were summarized.
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